ATLAS (AltaValve) Pivotal Trial (NCT06465745)
ATLAS (A Transseptal Left Atrial System for Treatment of Mitral Regurgitation) Pivotal Trial
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
Who can join: Review the eligibility criteria below.
Location: Banner University Medical Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (58 Sites)
Showing the first 25 of 58 sites.
- Banner University Medical Center — Phoenix, Arizona
- Abrazo Arizona Heart Hospital — Phoenix, Arizona
- Dignity Health; St. Joseph's Hospital and Medical Center — Phoenix, Arizona
- TMC Healthcare — Tucson, Arizona
- Scripps Health — La Jolla, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Orange County Heart Institute & Research Center — Orange, California
- Sutter Bay Hospitals — San Francisco, California
- Los Robles Hospital & Medical Center — Thousand Oaks, California
- Baptist Medical Center — Jacksonville, Florida
- NCH Healthcare System — Naples, Florida
- Sarasota Memorial Health Care System — Sarasota, Florida
- Wellstar Center for Cardiovascular Care — Atlanta, Georgia
- Cardiovascular Institute of the South — Houma, Louisiana
- MedStar Health Research Institute, Inc. — Baltimore, Maryland
- MedStar Health Research Institute, Inc. — Columbia, Maryland
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Henry Ford Hospital — Detroit, Michigan
- William Beaumont Hospital — Royal Oak, Michigan
- Minneapolis Heart Institute Foundation — Minneapolis, Minnesota
- Mayo Clinic — Rochester, Minnesota
- Saint Luke's Hospital of Kansas City — Kansas City, Missouri
- Washington University — St Louis, Missouri
- AHS Hospital Corp. — Morristown, New Jersey
📞 Contact the Study Coordinator
Phone: (602) 521-3090
Email: PBC-TREO-CR@arizona.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Mitral Regurgitation
- Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation — Birmingham, Alabama
- SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation — Los Angeles, California
- Beating Heart Mitral Valve Repair With the HARPOON™ System — San Francisco, California
- Prospective Treatment Algorithm Guiding Repair of Severe Ischemic Mitral Regurgitation — Ottawa, Ontario
- LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY — Ottawa, Ontario
- CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry — Tucson, Arizona
Explore by condition: All Mitral Regurgitation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.